Abiopharma

🔍 Tilenius Stephanie (Director)

Company: Seagate Technology Holdings plc (STX)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Sold 1,540 shares of Ordinary Shares at $766.5953 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 10,704.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 40 shares of Ordinary Shares at $767.33 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 10,664.00 | transaction_form_type: 4

Footnotes:

• F1: These Ordinary Shares were sold in multiple trades at prices ranging from $766.29 to $767.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.